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SUMMARY.-Medication with L-thyroxine or methylthiouracil of castrate rats
painted weekly 5, 10, 20 or 40 times with DMBA does not alter the order of
thresholds for carcinogenesis which increases from that for cervico-vaginal
epitheliomas via squamous celled and basal celled vulval tumours to cervico-
vaginal sarcomas. Methylthiouracil lowers the threshold for basal celled
vulval neoplasms.
Sarcomas reach a peak of25% with20 doses ofDMBAin non-medicated rats,
but rise to 90% and at a faster rate in animals given either of the thyroactive
drugs with further carcinogenic treatment.
The optimal dose phenomenon for cervico-vaginal epitheliomas, i.e. a
significant fall with continued painting from a peak reached by 5 to 20 doses of
DMBA, is not affected by medication with methylthiouracil or L-thyroxine.
Thyroactive compounds accelerate the formation of squamous celled vulval
tumours which reach a maximum with20 DMBA paintings; the total incidence
as well as the proportion of carcinomas to papillomas fallswith further treat-
ment.
Methylthiouracil promotes formation of basal celled vulval tumours at low
dose levels, but inhibits it at the highest. In medicated as in non-medicated
rats the induction of basal celled tumours ofthe vulva follows an optimum dose
pattern.
The optimal dose phenomenon and the effect of thyroactive compounds on
the tissue-specific sensitivity to carcinogens are discussed.
IN intact rats the incidence and rate of development of cervico-vaginal
sarcomas increases with increasing numbers of weekly applications of DMBA
ranging from 5 to 40, but in castrates a maximum incidence occurs at 20 doses and
further applications fail to increase the yield ofthese neoplasms. If, however, at
the level of about 40 doses castrate rats are given thyroactive substances such as
methylthiouracil or L-thyroxrine in the drinking water, the incidence of sarcomas
is increased and accelerated and surpasses that in intact animals. More epithelial
tumours ofthe cervico-vaginal tract are induced in castrate than in intact animals.
The high incidence with 5 to 20 weekly applications drops significantly with 40
paintings, thus establishing clearly an optimal regime ofcarcinogenic stimulation.
While in most instances increases in carcinogenic dosage cause either an increase
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in neoplasms or maintain tumour incidence at a maximal level as in the case of
cervico-vaginal sarcomas in castrates, the incidence of epithelial cervico-vaginal
tumours definitely decreases with increasing dosage.
For a given dose more tumours can be elicited by additional treatment with
various substances such asmethylthiouracil orL-thyroxine. Itthus seemspossible
that administration of these substances might also modify the optimal dosage
phenomenon and thus shed some light on its causation and mechanism.
For the present experiments castrate rats have been used since the phenomena
of optimal dosage, of maximal tumour incidence as well as of increase in tumour
incidence with dosage are more clearly seen than in similarly treated intact
animals. A comparison is made between castrate rats without additional treat-
ment and those given additionally either L-thyroxine or methylthiouracil in the
drinking water. All three treatment groups of animals have been painted with
DMBA either 5, 10, 20 or 40 times weekly.
MATERIALS AND METHODS
Hooded rats of the Lister strain, random bred within a closed colony in this
laboratory since 1940, were used. The animals were housed not more than seven
to a cage and given water and food pellets of1RC-diet 86 ad libitum. The thyro-
active substances were dissolved and administered in the drinking water. Only
animals surviving for at least 100 days after starting the experiment were con-
sidered at risk and the number of rats in the various treatment groups are given
in Table I.
TABLE I.-Additional Treatment, Number of Rats at Riskfor Different Numbers of
Weekly Applications ofDMBA and Duration ofExperiment
Duration of
experiment
Additional treatment Number at risk DMBA (days)
!;~ None . . . 22 x 5 . 770
22 xl1 647
46 . x 20 522
36 . x 40 . 406
L-thyroxine . . 19 x 5 . 780
21 . x 10 669
21 . X20 . 558
61 . x 40 . 322
Methylthiouracil . . 21 . x 5 . 725
20 . xlO . 578
21 . x 20 . 396
40 . x 40 323
Bilateral ovariectomy was performed with a dorsal approach under ether
anaesthesia on rats aged 5 to 6 weeks and carcinogenic treatment with a 1%
solution in acetone of 9,10-dimethyl-1,2-benzanthracene (DMBA, Koch-Light,
Ltd.) was started 2 to 3 weeks later. The vagina was stretched open by dorsal
flexion of the tail and the solution was applied by means of a cotton wool swab
mounted on a thin wire rod; it was distributed through a rotary motion over the
cervix, vagina and introitus. This procedure was repeated at weekly intervals
either for the life span of the animals (with an average of 40 applications) or
restricted to 5, 10 or 20 times (Table I).
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L-thyroxine sodium B.P. (Eltroxin, Glaxo) was added to the drinking water in
a concentration of 1 mg./1000 ml. giving a daily dose per rat of approximately
20 ,tg.
Methylthiouracil (B.D.H.) was administered in the drinking water (1 g./1000
ml.) in a daily dose of about 20 mg. per rat.
All animals were examined at weekly intervals and those with clinical signs of
vulval or vaginal tumours, or if sick, were killed and a post mortem performed.
In addition to the organs of the genital tract from ovary to vulva the following
tissues were fixed for histological examination: pituitary, thyroid, thymus,
lungs, liver, spleen, kidneys, adrenals, intestine and mesenteric, lumbar and
inguinal nodes. The material was fixed in Zenker-acetic or Bouin's fluid, de-
hydrated, embedded in paraffin and sectioned at 6 or 8 ,,- depending on the organ.
The endocrine glands and, when necessary, the cervix and vagina were sectioned
serially. Slides were stained with haematoxylin-eosin, the periodic acid-Schiff
technique (PAS) after diastase digestion, Van Gieson, carmalum-orange G-aniline
blue or Southgate's mucicarmine.
Calculation of results
In individual animals papillomas and carcinomas often coexisted at the same
site and the most advanced lesion was the criterion used in the classification of
tumour bearing rats. When animals had more than one distinct type ofneoplasm
they were recorded separately under sarcomas, squamous epitheliomas and basal
cell tumours.
For the age-specific induction rates the percentage of tumour bearing animals
amongst those at risk for consecutive 100-day periods was plotted at the 50-day
interval.
RESULTS
Histogenests of tumours of the cervico-vaginal tract and the vulva
The histogenesis of squamous celled cervico-vaginal and vulval tumours has
been described previously (Glucksmann and Cherry, 1970). A short account of
the histogenesis of basal celled vulval tumours induced by DMBA follows.
The majority ofbasal celled tumours arise from hair follicles though a few may
originate from the basal layer of the interfollicular epidermis. In contrast
squamous epitheliomas in the rat arise usually from hyperplastic interfollicular
epithelium. The earliest change in the follicle is the proliferation of cells of the
hair sheath or bulb and this is not associated with a localised inflammatory
reaction in the surrounding dermis (Fig. 1). Subsequently buds or finger-like
processes are formed (Fig. 2) and project within an intact basement membrane
into the unchanged dermis. These formations enlarge and grow downwards like
the normal hair follicle in anagen. Several neighbouring follicles may be involved
at the same time and may coalesce to a single larger tumour.
The expanding neoplasm pushes aside the surrounding dermis without eliciting
any cellular or stromal reaction. The tumour may appear as a circumscribed,
solid mass of basal cells or as multiple separate strands with or without inter-
vening stroma (Fig. 3 and 4). In some tumours abortive attempts at hair forma-
tion can be recognized; within the inner sheath the shaft is replaced by concentric
layers of parakeratotic cells (Fig. 4) and structures resembling hair bulbs with
771A. GLUCKSMANN AND CORA P. CHERRY
dermal papillae may be present. Occasionally a squamous component presents
in distinct foci of keratinizing squamous cells within the basal cell tumour or in
basosquamous foci with intermingling of basal and squamous cells (Howell, 1962).
Extensive central necrosis produces cystic tumours (Fig. 5).
In the vulva the panniculus carnosus has gaps through which hair follicles and
tumours may extend into the hypodermis. Thus the diagnosis of malignancy
cannot be based on penetration of the panniculus carnosus and rests on the cyto-
logical appearance of the tumour. Neoplasms, even though large, with little
mitotic activity but uniformity in cell and nuclear size are classified as papillomas
irrespective of their localization within the skin. Tumours with frequent and
abnormal mitoses, numerous degenerations, marked variation in cell and nuclear
size are classified as carcinomas even though they may be confined to the dermis.
Basal cell carcinomas spread by direct extension and invade the fat of the hypo-
dermis but extension by growth in the perineural and other lymphatic vessels has
not been observed in any of the experimental animals.
Effects of castration and of thyroactive compounds on normal tissues
The effects of castration on the female genital tract, ofthyroactive compounds
on the pituitary, the thyroid and the skin have been described previously (Cherry
and Glucksmann, 1970). Methylthiouracil has an inhibitory effect on the hair
cycle and causes hypoplasia or aplasia of the hair follicles resulting in generalized
alopecia. These changes extend to the vulval skin where the hair follicles are
atrophic, frequently abnormal and turn into keratinized cysts. Since basal cell
tumours arise from hair follicles prolonged administration ofmethylthiouracil may
have an influence on their induction.
The influence of thyroactive compounds on the induction of cervico-vaginal sarcomas
by 40, 20, 10 or 5 weekly doses ofDMBA
The dose-response curves (Fig. 6) show that additional treatment with either
methylthiouracil or L-thyroxine makes a substantial and significant difference in
incidence only at 40 paintings, though with methylthiouracil more sarcomas are
induced by 10 and 20 applications. Without medication the incidence of con-
nective tissue tumours drops slightly, but not significantly as the number of
DMBA doses is increased from 20 to 40.
The rate of tumour induction in the cervico-vaginal stroma measured by
EXPLANATION OF PLATES
FIG. 1. The vulval skin of a castrate rat treated with L-thyroxine showing an abnormal hair
follicle with branching projections 529 days after the first of 20 weekly applications ofDMBA.
There is some cellular infiltration in the dermis but no localized inflammatory reaction.
H. and E. x 210.
FIG. 2. Basal celled papilloma in the vulva of a methylthiouracil treated castrate rat 380 days
after the first of 20 weekly applications of DMBA. Remains of the hair shaft can be seen at
the right and structures resembling hair bulbs at the left of the figure. H. and E. x 115.
FIG. 3-4. Basal celled carcinoma in the vulva of a L-thyroxine treated castrate rat 404 days
after the first of 20 weekly applications ofDMBA. The intervening stroma and the replaco-
ment of a hair shaft by concentric layers of parakeratotic cells are seen at higher power in
Fig. 4. H. and E. xllO and x475.
FIG. 5.-Basal celled carcinoma of the vulva with central necrosis and degenerations in the
same rat as in Fig. 1. H. and E. x 110.
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Weekly Applications of DM BA
FIG. 6.-Dose response curves for cervico-vaginal tumours in castrate rats given
methylthiouracil (M), L-thyroxine (L) or no additional treatment (N).
cumulative percentage increase or by age-specific rates indicates a threshold level
around five paintings (Fig. 7-9): none are found in the methylthiouracil (Fig. 8) or
not additionally medicated groups (Fig. 7). Ofrats given L-thyroxine (Fig. 9) one
has produced a tumour early on with five and one with 10 paintings, but at 10
doses there are significantly fewer connective tissue tumours (Fig. 6) than in those
given methylthiouracil (difference 25 ± 11.3). In both groups treated with
thyroactive compounds the percentage of tumours increases with dose and the
duration of the induction period for the first sarcoma is shortened. Without
additionalmedicationthefirstsarcoma appearslaterwith 40thanwith 20paintings
and the rate oftumour formation is slowed down.
For the two medicated groups the difference in yield ofsarcomas is significant
between 10 and 20 and between 20 and 40 applications, while inthenon-medicated
group only the increase from 10 to 20 doses is significant (Fig. 10-12). The age-
specific percentage increases with time for 40 doses in rats given thyroactive
compounds (Fig. 8 and 9) and for 20 doses in methylthiouracil treated animals.
At the lower dose levels and in all non-medicated rats a relatively low peak value
(25%) is reached early on and later the incidence either fluctuates around it or
drops to nil.
The influence of thyroactive compounds on the induction of epithelial tumours in the
cervico-vaginal tract by 40, 20, 10 or 5-weekly doses ofDMBA
The dose-response curves (Fig. 6) show the same pattern for the three groups
of animals: the high incidence of tumours at 5, 10 and 20 paintings is reduced in
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the highest dose group when significantly more epithelial tumours occur in the
methylthiouracil than in the non-medicated rats. The additional medication
does not alter the general phenomenon of an optimal dose range with reduced
tumour incidence at higher levels. While the fall in epithelial tumours between
20 and 40 x DMBA is highly significant that for sarcomas in the non-medicated
group is slight and not significant (Fig. 6). Apart from the higher level of
epithelial tumours in the methylthiouracil treated group at x40, and from a
significantly lower incidence oftumours at 5 x DMBA in the L-thyroxine treated
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FIG. 7.-Age-specific rates of tumour induction by 40, 20, 10 or 5 weekly
applications ofDMBA in the cervico-vaginal tract of castrate rats.
group, the medication with thyroactive substances does not appear to have greatly
affected the sensitivity of the cervico-vaginal epithelium to carcinogenic stimula-
tion.
Tumour induction (Fig. 7-9) increases and accelerates with dose in the range
of 5 to 20 doses but slows down at 40 DMBA administrations. The threshold
level lies between one and five applications and is thus considerably lower than
thatforsarcomas. ThegreaternumberofDMBA dosesreducesthetotalincidence
of epithelial tumours and also the proportion of papillomas to carcinomas (Fig.
10-12). At 20 and even at 10 applications carcinomas account for 50% or more
ofall epithelial tumours, while at 40 doses there are either no carcinomas as in the
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non-medicated and in the methylthiouracil treated groups (Fig. 1O and 11) or only
a very low incidence (2%) in relation to that of papillomas (15%, Fig. 12).
The inverse relationship between incidence of epithelial neoplasms and dose of
carcinogen may be due to the shortening of the total induction period by more
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FIG. 8.-Age-specific rates of tumour induction by 40, 20, 10 or 5 weekly
applications of DMBA in the cervico-vaginal tract of castrate rats given methylthiouracil.
TABLE II.-Epithelial Tumours of the Cervico-Vaginal Tract in Castrate Rats
Nil
Days %
-+273 9
-406 21
-+273 45
-+522 87
Total %00S.E.
11+5-2
67±6-9
Additional
Methylthiouracil
Days %
-.273 24
-*344 43
-*273 54
-+396 88
Total % +S.E.
30+7 -2
66±10-3
L-Thyroxine
Days %
273 13
-*322 60
-*273 0
-*558 70
Total %±S.E.
16±4-7
58±10-8
For the same treatment group the differences in total yield at 20 and 40 DMBA paintings are
statistically significant. At 40 x DMBA the total yield in the methylthiouracil group is significantly
greater than that in the non-medicated group.
Treatments
DMBA
x 40
x 20
x 40
x 20
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FIG. 9.-Age-specific rates of tumour induction by 40, 20, 10 or 5 weekly
applications of DMBA in the cervico-vaginal tract of castrate rats given L-thyroxine.
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FIa. 10.-The induction by DMBA of tumours in the cervix and vagina of spayed rats.
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numerous applications or to an inhibiting effect of continued DMBA treatment.
Table II contrasts the incidence of epithelial tumours within the period of 40
weekly applications (273 days) with that occurring subsequently and compares
40 with 20 doses. The incidence of epithelial tumours is always greater after
Sarcomas
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FIG. 11.-The induction by DMBA of tumours in the cervix and vagina of spayed
rats given methylthiouracil.
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FIG. 12.-The induction by DMBA of tumours in the cervix and vagina of spayed
rats given L-thyroxine.
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273 days than before whether or not DMBA has been given for half the earlier
period. With the exception ofthe L-thyroxine treated rats, the tumour incidence
is at least twice as big with 20 than with 40 doses in the earlier and in the later
period. Reduction of the experimental period is not the only factor in reducing
the yield of epithelial neoplasms in the highest dose group since in the non-
medicated rats treated 40 times the total yield is 11% in 406 days while in the
methylthiouracil medicated group painted 20 times it is 66% in 396 days. There
are no carcinomas in the former, but halfthe total tumours are carcinomas in the
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FIG. 13.-Induction of vulval tumours by 40, 20, 10 or 5 weekly applications of
DMBA in spayed rats.
medicated animals. These highly significant figures make it unlikely that the
differences in the duration ofthe experiment alone account for the fall in incidence
of epithelial tumours with increased number of applications.
The formation of sarcomas does not interfere with that of epithelial tumours
of the cervico-vaginal tract since in the methylthiouracil treated animals painted
20 times (Fig. 8) the induction rates for sarcomas and epithelial tumours are
practically identical. Furthermore with 40 doses of DMBA the percentage of
sarcomas is high in the two medicated groups and low in the non-medicated rats
while the incidence ofepithelial tumours is roughly the same.
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The influence of thyroactive compounds on the induction of squamous celled vulval
tumours by 40, 20, 10 or 5 weekly doses ofDMBA
In non-medicated rats the speed of induction and total yield of squamous
celled tumours ofthe vulva increases with number ofDMBA applications (Fig. 13).
This is most marked at between 10 and 20 doses, while between 20 and 40 applica-
tions tumour induction is accelerated, but the total yield is not increased signi-
ficantly. Methylthiouracil medication (Fig. 14) raises and speeds significantly
the induction of squamous epitheliomas with 10 doses as compared with the non-
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FIG. 14.-Induction of vulval tumours by 40, 20, 10 or 5 weekly applications of
DMBA in spayed rats given methylthiouracil.
medicated group and that given L-thyroxine (Fig. 15). With 40 doses there are
fewer neoplasms but they appear more rapidly than with 20 doses (Fig. 14).
Additional treatment with L-thyroxine slows down the rate of tumour induction
at all levels with a maximum yield at 20 doses. At 40 applications the total
incidence is significantly less than in the other two treatment groups. The
proportion of.carcinomas to papillomas is lower at 40 than at 20 doses in rats
given thyroactive compounds, while in non-medicated animals it increases with
the more numerous applications ofDMBA (Fig. 16-18).
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FIG. 15.-Induction of vulval tumours by 40, 20, 10 or 5 weekly applications of
DMBA in spayed rats given L-thyroxine.
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FIG. 16.-The induction by DMBA of vulval turmours in spayed rats.
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The threshold for the induction of squamous celled tumours of the vulva lies
below five doses, but is probably higher than that for epithelial tumours of the
vagina, since here about three times as many tumours are inducedby fivepaintings
as in the vulva.
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FIG. 17.-The induction by DMBA of vulval tumours in spayed rats given methylthiouracil.
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FIG. 18.-The induction by DMBA of vulval tumours in spayed rats given L-thyroxine.
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The rate for malignant conversion of vulval squamous tumours is not a simple
function of the duration of the experimental period: the highest proportion of
carcinomas to papillomas is found around the 400-day period (40 x DMBA
without medication, 20 x DMBA with methylthiouracil, Fig. 13-18).
The influence ofthyroactive compounds on the induction of basal celled vulval tumours
by 40, 20, 10 or 5 weekly doses of DMBA
In the non-medicated group (Fig. 16) the incidence of basal cell tumours
increases significantly between 10 and 20 doses and significantly decreases when
40 paintings are given. The proportion of carcinomas to papillomas also falls
with the larger number of applications. The pattern in the L-thyroxine treated
group is very similar: a significant increase in tumours up to 20 doses, a fall in
total incidence and of carcinomas with 40 applications (Fig. 18). Significantly
more basal cell tumours are induced by 5 DMBA and significantly less by 40
DMBA applications in the methylthiouracil treated rats compared with the other
groups. The level of tumour incidence achieved by 5 paintings is maintained by
10 and 20 but here also some carcinomas occur (Fig. 17). With 40 doses no basal
celled neoplasms are induced. For this treatment there is thus a low threshold
dose as well as an optimal dose regime.
The speed of tumour production increases with number up to 20 doses and in
rats given L-thyroxine also up to 40 doses (Fig. 13-15), although the total incidence
is lower than in the other groups (Fig. 16-18). On the whole, the speed of induc-
tion and total yield ofbasal cell tumours lags behind that ofsquamous cell tumours
ofthe vulva. The diminution in tumour incidence and in proportion ofcarcinomas
at the highest number ofdoses is more pronounced for the basal celled than for the
squamous celled epitheliomas. The methylthiouracil effect on basal celled differs
from that on the squamous celled tumours presumably because the former arise
predominantly from the hair follicles and the latter mainly from the interfollicular
stretches of the epidermis.
DISCUSSION
The threshold for carcinogenesis varies with tissue within the female genital
tract of rats, with endocrine status and with additional treatment. It is lowest
for the cervico-vaginal epithelium, lower in castrates than in intacts (Glucksmann
and Cherry, 1970) and in castrates slightly increasedbytreatmentwithL-thyroxine.
It is slightly higher for squamous celled neoplasms of the vulva and still higher
for basal celled epitheliomas at the same site. Castration does not affect the
incidence of these tumours nor the threshold (Glucksmann and Cherry, 1970)
which in castrates is lowered for basal celled tumours by methylthiouracil. The
minimal dose for cervico-vaginal sarcomas is higher than for any of the epithelial
tumours ofthe female genital tract ofrats. In all these instances the threshold is
judged by the percentage of tumours induced by the minimal number of weekly
paintings, i.e. five. In addition to differences in tissue sensitivity which are
influenced by castration (Glucksmann and Cherry, 1958) and by additional treat-
ments (Cherry and Glucksmann, 1960 and 1968; Glucksmann and Cherry, 1968),
the individual sensitivity plays a role. Thus the group of rats treated with L-
thyroxine contained only one animal in which the cervico-vaginal stroma was
very sensitive to five and one only was sensitive to 10 paintings. The tumours
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occurred very early and none of the other rats of these groups had sarcomas even
after prolonged periods ofobservation. Individual sensitivity must beresponsible
also for the variations in the duration of the induction period in any one experi-
mental group, though differences between diversely treated groups are due to the
treatments rather than to random selection of particularly sensitive animals into
one group. This is best demonstrated by the fact that the same results are
obtained if experiments are repeated after intervals of some years (Glucksmann
and Cherry, 1968).
Increasing the number of carcinogenic stimuli may (1) increase the yield of
induced tumours inproportion or up to a maximal dose, but may actually decrease
it after an optimal dose or (2) accelerate tumour formation by shortening the
period before the first neoplasm appears and by increasing the rate ofsubsequent
tumour formation. These two actions are not necessarily linked: acceleration of
carcinogenesis may occur without an increase in percentage ofinduced neoplasms
(basal celled epitheliomas, Fig. 14 and 15) though the two actions are often asso-
ciated (squamous celled tumours ofthe vulva, Fig. 13-15; sarcomas, Fig. 8 and 9).
Thyroactive compounds given to castrates accelerate and increase the produc-
tion of sarcomas, while in non-medicated rats a maximal incidence is reached by
20 doses. A similar maximum is obtained by 20 doses for squamous celled
tumours of the vulva and for the proportion of carcinomas to papillomas. With
40 applications the percentage of carcinomas remains at the same level, except for
methylthiouracil treated animals where it drops significantly. For basal celled
tumours of the vulva a peak value is reached with 20 paintings and with 40
applications (Fig. 16-18) there is a fall and also a decrease in the proportion of
carcinomas to papillomas. A similar optimal dose phenomenon obtains for
epithelial cervico-vaginal tumours (Fig. 6, 10-12). While thyroactive compounds
increase the induction of sarcomas with an increase from 20 to 40 doses, they do
not enhance similarly the formation of epithelial tumours (Fig. 6). There is thus
a tissue specific effect of the thyroactive compounds on the components of the
cervico-vaginal tract undergoing carcinogenesis and this is demonstrated by some
further observations: with 40 times DMBA carcinogenesis in castrate rats made
diabetic by alloxan treatment results in 75% ± 9.7 epithelial tumours and
95% ± 4-9 sarcomas in a period of 362 days; in castrate rats given stilboestrol on
3 consecutive days per week the promoting effect is more marked for epithelial
tumours with an incidence of74% + 9-1 than for sarcomas with only 52% ± 10-4
in 271 days. The incidence of epitheliomas is similar in these examples but there
is a significant difference in that of sarcomas (43 ± 11.1). For the same dose of
carcinogens there are thus in the same organ instances of equal promotion of
carcinogenesis in the epithelium and stroma and for promotion in only one or the
other component. The effect of stilboestrol given 3 x weekly like that of
thyroactive compounds on the epitheliomas ofthe vulva does not differ from that
in diabetic castrate rats and again emphasises the tissue specificity of the sensi-
tising action of various compounds on carcinogenesis.
While an increase in tumour formation with dose proportionately or up to a
maximum and acceleration of tumour formation may be attributed to either a
greater number ofinitiated cells orto a promoting action on initiated cells or both,
the phenomenon of an optimal dose with a decreased carcinogenesis following
more numerous applications of DMBA is more difficult to explain. As pointed
out previously, there is no evidence of a toxic action in the form of increased cell
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deaths with more doses in the cervico-vaginal epithelium, which in fact is hyper-
trophic (Glucksmann and Cherry, 1970); nor is there any evidence that continued
painting inhibits tumour formation under suitable conditions (Table II). The
high incidence of epithelial tumours in diabetic rats painted 40 times is further
evidence that increased numbers of paintings per se do not inhibit carcinogenesis.
Indeed it shows that the optimal dose phenomenon can be overcome by suitable
stimulation, i.e. by castration plus diabetes. This applies to the cervico-vaginal
epitheliomas, but whether it holds under different conditions also for the basal
celled vulval neoplasms has yet to be established.
In previous papers (Glucksmann and Cherry, 1968; Cherry and Glucksmann,
1968, 1970) it has been shown that the action of castration and of additional
hormonal treatment on carcinogenesis in the female genital tract differs from that
on the normal structures ofthese organs and from the action on target tissues in
the body as well as on growth of the body. The present paper reinforces these
findings and the conclusion that central regulatory factors such as sensitization by
castration to additional treatments and changes in local reactivity of specific
tissue elements must be responsible for the effects ofvariations in doses ofDMBA
on carcinogenesis.
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